Delcath Systems Inc (OQ:DCTH)
Business Focus: Medical Prosthetics
| Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 566 Queensbury Avenue QUEENSBURY NY 12804 |
| Tel: | N/A |
| Website: | https://delcath.com |
| IR: | See website |
| Key People | ||
| Gerard J. Michel Chief Executive Officer, Director | Martha S. Rook Chief Operating Officer | John Purpura Executive Vice President - Global Head of Operations |
| Sandra Pennell Senior Vice President - Finance, Chief Accounting Officer, Executive Officer | Johnny John Senior Vice President - Clinical Development and Medical Affairs | David Hoffman Chief Compliance Officer, General Counsel, Corporate Secretary |
| Anthony Dias Vice President - Finance | Vojislav Vukovic Chief Medical Officer | |
| Business Overview |
| Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers. The Company's products, HEPZATO KIT (Hepzato (melphalan) for Injection/Hepatic Delivery System) and CHEMOSAT Hepatic Delivery System for Melphalan (CHEMOSAT) percutaneous hepatic perfusion (PHP) are designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects during a PHP procedure. HEPZATO KIT is a drug/device combination product designed to administer high-dose chemotherapy directly into the liver while limiting systemic exposure and associated side effects. In Europe, the hepatic delivery system is a stand-alone medical device having the same device components as HEPZATO KIT, but without the melphalan hydrochloride and is approved for sale under the trade name CHEMOSAT. In the United States, HEPZATO is regulated as a drug by the United States Food and Drug Administration (FDA). |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Delcath Systems Inc revenues decreased 24% to $2.1M. Net loss increased 31% to $47.7M. Revenues reflect Product revenue decrease of 19% to $2.1M, Other revenue decrease from $171K to $0K. Higher net loss reflects Selling, general and administrative - increase of 59% to $17.2M (expense), Stock-based Compensation in R&D increase of 16% to $2.8M (expense). |
| Employees: | 76 as of Mar 18, 2024 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $97.13M as of Dec 31, 2023 |
| Annual revenue (TTM): | $2.07M as of Dec 31, 2023 |
| EBITDA (TTM): | -$38.05M as of Dec 31, 2023 |
| Net annual income (TTM): | -$47.68M as of Dec 31, 2023 |
| Free cash flow (TTM): | -$31.31M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | N/A |
| Shares outstanding: | 25,439,319 as of Mar 28, 2024 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.